The product is being recalled due to a label error on declared
strength. Bottles labelled as Mirtazapine 7.5 mg may contain 15 mg
tablets, as per the company's announcement posted on the website of
the United States Food and Drug Administration (USFDA).
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/aurobindo-pharma-inc-recalls-mirtazapine-tablets-in-us/articleshow/73074462.cms
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment